• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去氧皮质酮盐性高血压大鼠心房利钠肽血管受体密度降低。

Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.

作者信息

Schiffrin E L, St-Louis J

出版信息

Hypertension. 1987 May;9(5):504-12. doi: 10.1161/01.hyp.9.5.504.

DOI:10.1161/01.hyp.9.5.504
PMID:3032791
Abstract

We have previously found that vascular receptors for atrial natriuretic peptide (ANP) in the rat are down-regulated by volume expansion. For this reason vascular ANP receptor density and affinity were examined in a model of volume-expanded hypertension, the deoxycorticosterone acetate (DOCA)-salt hypertensive rat. The density of mesenteric vascular ANP binding sites was decreased in DOCA-salt hypertensive rats from a control value in uninephrectomized rats of 203 +/- 25 fmol/mg protein to 60 +/- 13 fmol/mg protein (p less than 0.01). The sensitivity of norepinephrine-precontracted aorta to ANP was significantly reduced in DOCA-salt hypertensive rats (p less than 0.001). DOCA-salt hypertensive rats infused intravenously for 4 days with ANP, 100 to 300 ng/hr, did not experience a lowering of blood pressure, in contrast to the significant reduction in blood pressure seen in two-kidney, one clip Goldblatt hypertensive rats similarly infused. In the latter there was no natriuretic response to ANP, while in the DOCA-salt hypertensive rats natriuresis occurred without lowering of blood pressure. In the DOCA-salt hypertensive rats plasma ANP concentration was increased to 68 +/- 8 fmol/ml from 10 +/- 1 fmol/ml in uninephrectomized rats. In conclusion, raised ANP concentration in plasma of volume-expanded hypertensive rats (DOCA-salt hypertension) may result in decreased density of ANP vascular receptors. These results suggest that a decrement in the number of ANP receptors may be a cause of decreased sensitivity of vascular responses to ANP in vitro and resistance to the blood pressure-lowering action of ANP in vivo.

摘要

我们先前发现,大鼠心房利钠肽(ANP)的血管受体可因容量扩张而下调。因此,我们在容量扩张型高血压模型——醋酸脱氧皮质酮(DOCA)-盐性高血压大鼠中,检测了血管ANP受体的密度和亲和力。DOCA-盐性高血压大鼠肠系膜血管ANP结合位点的密度,从未切除一侧肾脏大鼠的对照值203±25 fmol/mg蛋白降至60±13 fmol/mg蛋白(p<0.01)。DOCA-盐性高血压大鼠中,去甲肾上腺素预收缩主动脉对ANP的敏感性显著降低(p<0.001)。与同样输注ANP的两肾一夹型Goldblatt高血压大鼠血压显著降低相反,静脉输注ANP(100至300 ng/小时)4天的DOCA-盐性高血压大鼠血压并未降低。在后者中,对ANP无利钠反应,而在DOCA-盐性高血压大鼠中,利钠作用发生但血压未降低。DOCA-盐性高血压大鼠血浆ANP浓度从未切除一侧肾脏大鼠的10±1 fmol/ml升至68±8 fmol/ml。总之,容量扩张型高血压大鼠(DOCA-盐性高血压)血浆中升高的ANP浓度可能导致ANP血管受体密度降低。这些结果表明,ANP受体数量的减少可能是体外血管对ANP反应敏感性降低以及体内对ANP降压作用产生抵抗的原因。

相似文献

1
Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.去氧皮质酮盐性高血压大鼠心房利钠肽血管受体密度降低。
Hypertension. 1987 May;9(5):504-12. doi: 10.1161/01.hyp.9.5.504.
2
Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.去氧皮质酮盐性高血压大鼠肾乳头中的心房利钠肽受体
Am J Physiol. 1990 Jul;259(1 Pt 2):F130-7. doi: 10.1152/ajprenal.1990.259.1.F130.
3
[The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats].[去氧皮质酮盐高血压大鼠肺和肾中利钠肽受体(NP-R)的变化]
Nihon Naibunpi Gakkai Zasshi. 1995 May 20;71(4):587-96. doi: 10.1507/endocrine1927.71.4_587.
4
Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.内源性心房利钠肽在去氧皮质酮盐高血压大鼠中的作用。一种新型心房利钠肽受体非肽拮抗剂的作用
Circulation. 1993 Feb;87(2):554-61. doi: 10.1161/01.cir.87.2.554.
5
Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.用抗心钠素单克隆抗体对内源性心钠素进行慢性阻断,可加速自发性高血压大鼠和醋酸脱氧皮质酮-盐性高血压大鼠高血压的发展。
J Clin Invest. 1989 Jul;84(1):145-54. doi: 10.1172/JCI114134.
6
Regulation of receptors for atrial natriuretic peptide in the rat and human.大鼠和人类中的心钠素受体调节
Cardiovasc Drugs Ther. 1988 Nov;2(4):493-500. doi: 10.1007/BF00051188.
7
Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: comparative receptor localization and changes in different hypertension models in the rat.高血压大鼠不同组织中血管紧张素II和心房利钠因子结合位点:受体定位比较及不同高血压模型中的变化
Endocrinology. 1989 Jun;124(6):2799-808. doi: 10.1210/endo-124-6-2799.
8
Vascular receptors for atrial natriuretic peptide in hypertension.高血压中的心钠素血管受体
Int J Rad Appl Instrum B. 1990;17(7):673-6. doi: 10.1016/0883-2897(90)90083-d.
9
Vascular receptors for angiotensin, vasopressin, and atrial natriuretic peptide in experimental hypertension.实验性高血压中血管紧张素、血管加压素和心房利钠肽的血管受体
Can J Physiol Pharmacol. 1989 Sep;67(9):1118-23. doi: 10.1139/y89-178.
10
Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody.心房利钠多肽基因表达增强在去氧皮质酮-盐性高血压中的病理生理作用。心房利钠多肽单克隆抗体的作用
Am J Hypertens. 1991 Jan;4(1 Pt 1):39-44. doi: 10.1093/ajh/4.1.39.

引用本文的文献

1
Regulation of receptors for atrial natriuretic peptide in the rat and human.大鼠和人类中的心钠素受体调节
Cardiovasc Drugs Ther. 1988 Nov;2(4):493-500. doi: 10.1007/BF00051188.
2
[Atrial natriuretic peptide and its significance for arterial hypertension].[心房利钠肽及其在动脉高血压中的意义]
Klin Wochenschr. 1989 Nov 3;67(21):1069-76. doi: 10.1007/BF01741781.
3
Atrial natriuretic peptide and angiotensin II binding sites in cerebral capillaries of spontaneously hypertensive rats.自发性高血压大鼠脑毛细血管中的心钠素和血管紧张素II结合位点
Cell Mol Neurobiol. 1989 Jun;9(2):221-31. doi: 10.1007/BF00713030.